Halder Venture Limited Allots 7.94 Lakh Equity Warrants at ₹315 Each
Halder Venture Limited approved the allotment of 7,93,650 Equity Convertible Warrants at ₹315 each to P.K. Bio Link Private Limited on July 24, 2026. The warrants carry a face value of ₹10 and a premium of ₹305.
The allotment of warrants at a premium indicates investor confidence and provides capital to the company, which can have a medium-term impact on its financial health and growth prospects.
The company is raising capital through the preferential allotment of warrants, which is generally viewed positively as it can fund growth or operational needs.
Halder Venture Limited announced the allotment of 7,93,650 Equity Convertible Warrants on a preferential basis to a Non-Promoter group. The face value of each warrant is ₹10, with a premium of ₹305, making the issue price ₹315 per warrant. The company has received 25% of the subscription amount from the warrant holder.
The Board of Directors, in a meeting held on July 24, 2026, approved this allotment. This action follows the approval granted by shareholders through postal ballot on April 29, 2026, and in-principle approvals from both BSE and NSE, dated July 09, 2026.
The allotment was made to P.K. Bio Link Private Limited, categorized under Non-Promoter. The meeting of the Board of Directors commenced at 03:00 P.M. and concluded at 04:15 P.M. on July 24, 2026.
What to do with a filing like this
Halder Venture Limited filed this with the NSE as a statutory disclosure, categorised under equity fundraising. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Halder Venture Limited. Read the original for the full detail.